Plato Investment Management Ltd

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1984475 SYDNEY, C3

Position in VRTX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$3,021,608

+$371,394 QoQ

Shares Held

6,083

+2.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#578

of 1,735 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Plato Investment Management Ltd holds $8,720,382 across 6 Biotechnology names. VRTX ranks #1 (34.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	6,083	$3,021,608
2	REGN	Regeneron Pharmaceuticals, Inc.	3,983	$2,483,559
3	INCY	Incyte Corp	14,856	$1,684,076
4	ALNY	Alnylam Pharmaceuticals, Inc.	3,671	$1,105,081
5	EXEL	Exelixis, Inc.	5,702	$310,245
6	BMRN	Biomarin Pharmaceutical Inc	2,024	$115,813

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,021,608	6,083	+2.5%	Shares	Sole	2026-08-07
2026-03-31	$2,650,214	5,935	0.0%	Shares	Sole	2026-05-05
2025-12-31	$2,690,691	5,935	-1.5%	Shares	Sole	2026-02-04
2025-09-30	$2,360,022	6,026	+3.4%	Shares	Sole	2025-11-05
2025-06-30	$2,595,070	5,829	+0.1%	Shares	Sole	2025-08-05
2025-03-31	$2,824,076	5,825	-12.3%	Shares	Sole	2025-05-20
2024-12-31	$2,675,941	6,645	0.0%	Shares	Sole	2025-02-06
2024-09-30	$3,090,456	6,645	0.0%	Shares	Sole	2024-11-06
2024-06-30	$3,114,644	6,645	+8.2%	Shares	Sole	2024-08-09
2024-03-31	$2,566,581	6,140	+677.2%	Shares	Sole	2024-05-17
2023-12-31	$321,443	790	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.